Literature DB >> 19343322

Predictors of bacteraemia and mortality in patients with acute liver failure.

Constantine J Karvellas1, Fred Pink, Mark McPhail, Timothy Cross, Georg Auzinger, William Bernal, Elizabeth Sizer, Demetrios J Kutsogiannis, Ian Eltringham, Julia A Wendon.   

Abstract

PURPOSE: To determine what physiological and biochemical factors predict development of bacteraemia and mortality in patients with acute liver failure (ALF).
METHODS: Retrospective analysis of 206 ALF patients admitted to a specialist liver intensive therapy unit (LITU) from January 2003 to July 2005 (data collected prospectively).
RESULTS: A total of 206 patients were defined with ALF: 72 (35%) suffered bacteraemia (BAClf) and 134 (65%) did not (NBAClf). Gram positive organisms were observed in 44% of isolates, gram negatives in 52% and fungaemia in 4%. Median time to first bacteraemia was 10 (7-16) days. On admission, BAClf patients had higher SIRS scores and degrees of hepatic encephalopathy (HE). During their LITU course, BAClf patients had significantly increased requirements for renal replacement therapy (RRT), mechanical ventilation, and longer median LITU stay. Multivariate analysis (logistical regression) demonstrated significant predictors of bacteraemia on admission were HE grade >2 (Odds Ratio 1.6) and SIRS score >1 (OR 2.7). In all patients, independent predictors of mortality (logistical) were age (OR 1.41), maximum HE grade pre-intubation (1.76), Lactate (1.14) and Acute Physiology and Chronic Health Evaluation II score (APACHEII) (1.09), but not bacteraemia. Transplantation was protective (OR 0.20).
CONCLUSION: In this study, severity of hepatic encephalopathy and SIRS score >1 were predictive of bacteraemia. APACHEII was independently predictive of mortality in all ALF patients but not bacteraemia.

Entities:  

Mesh:

Year:  2009        PMID: 19343322     DOI: 10.1007/s00134-009-1472-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  34 in total

Review 1.  Ventilator-associated pneumonia. Prevention, diagnosis, and therapy.

Authors:  Sean P Keenan; Daren K Heyland; Michael J Jacka; Deborah Cook; Peter Dodek
Journal:  Crit Care Clin       Date:  2002-01       Impact factor: 3.598

Review 2.  Septic shock: pathogenesis.

Authors:  M P Glauser; G Zanetti; J D Baumgartner; J Cohen
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

3.  Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures.

Authors:  Pieter Depuydt; Dominique Benoit; Dirk Vogelaers; Geert Claeys; Gerda Verschraegen; Koenraad Vandewoude; Johan Decruyenaere; Stijn Blot
Journal:  Intensive Care Med       Date:  2006-09-16       Impact factor: 17.440

Review 4.  The importance of immune dysfunction in determining outcome in acute liver failure.

Authors:  Charalambos Gustav Antoniades; Philip A Berry; Julia A Wendon; Diego Vergani
Journal:  J Hepatol       Date:  2008-08-21       Impact factor: 25.083

5.  Timing and aetiology of bacterial infections in a liver intensive care unit.

Authors:  J Wade; N Rolando; J Philpott-Howard; J Wendon
Journal:  J Hosp Infect       Date:  2003-02       Impact factor: 3.926

6.  Serum stimulatory activity and polymorphonuclear leucocyte movement in patients with fulminant hepatic failure.

Authors:  R J Wyke; A G Yousif-Kadaru; I A Rajkovic; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

7.  Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia.

Authors:  P Depuydt; D Benoit; D Vogelaers; J Decruyenaere; D Vandijck; G Claeys; G Verschraegen; S Blot
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

Review 8.  The pathogenesis of sepsis.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

9.  Primary sepsis presenting as fulminant hepatic failure.

Authors:  L Y Dirix; R J Polson; A Richardson; R Williams
Journal:  Q J Med       Date:  1989-11

10.  Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients.

Authors:  Antonella Agodi; Martina Barchitta; Rosalba Cipresso; Loredana Giaquinta; Maria Antonietta Romeo; Carmelo Denaro
Journal:  Intensive Care Med       Date:  2007-05-15       Impact factor: 17.440

View more
  17 in total

Review 1.  Management in acute liver failure.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2014-12-03

Review 2.  Approach to clinical syndrome of jaundice and encephalopathy in tropics.

Authors:  Anil C Anand; Hitendra K Garg
Journal:  J Clin Exp Hepatol       Date:  2014-06-06

3.  Surveillance for infectious complications in pediatric acute liver failure - a prospective study.

Authors:  Suresh Mekala; Barath Jagadisan; Subhash Chandra Parija; Subitha Lakshminarayanan
Journal:  Indian J Pediatr       Date:  2014-06-20       Impact factor: 1.967

4.  Antibiotics in Acute Liver Failure (ALF).

Authors: 
Journal:  J Clin Exp Hepatol       Date:  2015-02-10

5.  Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study.

Authors:  Constantine J Karvellas; Jorge Cavazos; Holly Battenhouse; Valerie Durkalski; Jody Balko; Corron Sanders; William M Lee
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-25       Impact factor: 11.382

Review 6.  Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-01-08       Impact factor: 17.440

Review 7.  Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy.

Authors:  Mhairi C Donnelly; Peter C Hayes; Kenneth J Simpson
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

8.  Clinical characteristics and corticosteroid therapy in patients with autoimmune-hepatitis-induced liver failure.

Authors:  Bing Zhu; Shao-Li You; Zhi-Hong Wan; Hong-Ling Liu; Yi-Hui Rong; Hong Zang; Shao-Jie Xin
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  Improved prescription of taohechengqi-tang alleviates D-galactosamine acute liver failure in rats.

Authors:  Yang Zhang; Jian-Xing Luo; Xiao-Yu Hu; Fang Yang; Sen Zhong; Wu Lin
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

10.  Prognostic significance of infections in critically ill adult patients with acute liver injury: a retrospective cohort study.

Authors:  Alexander D Zider; Radhika Zopey; Ronak Garg; Xiaoyan Wang; Tisha S Wang; Jane C Deng
Journal:  Liver Int       Date:  2016-04-04       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.